Cibiem, Inc. Company
Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. The company was co-founded by Mark Gelfand and Howard R. Levin, M.D., the proven team of innovators and entrepreneurs behind Coridea. The company is backed by top-tier venture investors Third Rock Ventures and SV Life Sciences.
Industry:
mHealth
Headquarters:
Los Altos, California, United States
Zip:
1-10
Founded Date:
2010-12-01
Employees Number:
1-10
Acquisitions Number:
2
Investors Number:
13000000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Debt Financing
Last Funding Type:
info@cibiem.com
Register and Claim Ownership